Drain Removal Before Versus After CPM in Primary Total Knee Arthroplasty
1 other identifier
interventional
104
1 country
1
Brief Summary
The aim of this prospective randomized controlled study was to determine whether the timing of drain removal in relation to continuous passive motion (CPM) application influences postoperative residual hematoma formation following primary total knee arthroplasty (TKA). Our primary hypothesis was that removing the drain after initiating CPM would result in less residual hematoma, as CPM-induced intra-articular fluid and blood mobilization would be evacuated through the drain before its removal, thereby reducing postoperative fluid accumulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2025
CompletedFirst Submitted
Initial submission to the registry
December 10, 2025
CompletedFirst Posted
Study publicly available on registry
December 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedDecember 24, 2025
December 1, 2025
7 months
December 10, 2025
December 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Residual Hematoma Formation
Residual hematoma formation assessed by knee circumference measurements at the level of the superior pole of the patella. Circumference is measured on both the operated and contralateral knees. The difference from baseline and between-group differences are evaluated.
Preoperative; Postoperative Day 2; Day 14; Day 28
Secondary Outcomes (6)
Wound Healing
Postoperative Day 2; Day 14
Range of Motion (ROM)
Preoperative; Postoperative Day 2; Day 14; Day 28
Pain Assessment
Preoperative; Postoperative Day 14; Day 28
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Preoperative; Postoperative Day 28
Lysholm Knee Score
Preoperative; Postoperative Day 28
- +1 more secondary outcomes
Study Arms (2)
Drain Removal Before CPM
OTHERThe hemovac drain is removed approximately 24 hours after surgery, immediately before a standardized 1-hour CPM session performed at 0-90° flexion. All other perioperative and rehabilitation protocols are identical between groups.
Drain Removal After CPM
OTHERPatients undergo a standardized 1-hour CPM session at 0-90° flexion approximately 24 hours after surgery. The hemovac drain is removed immediately after completion of the CPM session. All other perioperative and rehabilitation protocols are identical between groups.
Interventions
Hemovac drain removal performed approximately 24 hours after primary TKA, immediately before a standardized 1-hour CPM session (0-90°). All other surgical, perioperative, and rehabilitation protocols are identical across study arms.
A standardized 1-hour CPM session at 0-90° is administered approximately 24 hours after primary TKA. The hemovac drain is removed immediately after completion of the CPM session. All other surgical, perioperative, and rehabilitation protocols are identical across study arms.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Undergoing primary unilateral total knee arthroplasty (TKA) for end-stage knee osteoarthritis
- Able to provide written informed consent
- Able to comply with scheduled postoperative follow-up assessments
You may not qualify if:
- Revision total knee arthroplasty
- Previous infection in the index knee
- Inflammatory arthropathy
- Neuromuscular disorders affecting lower extremity function
- Inability to attend follow-up visits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Etlik City Hospital
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Orthopedic Surgeon, Principal Investigator
Study Record Dates
First Submitted
December 10, 2025
First Posted
December 24, 2025
Study Start
June 15, 2025
Primary Completion
December 30, 2025
Study Completion
December 30, 2025
Last Updated
December 24, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share